Zepbound Cost: Is It Cheaper Than Wegovy?
Last updated: March 24, 2026
Quick Answer: Zepbound (tirzepatide) costs $299–$499 per month through Eli Lilly’s self-pay program, while Wegovy injectable pens cost $199–$349 per month through Novo Nordisk’s program — making Wegovy slightly cheaper for most uninsured patients. However, the new oral Wegovy pill launched in January 2026 drops that cost to as low as $149 per month Zepbound Cost, widening the gap further. With commercial insurance and savings cards, both drugs can cost as little as $0–$25 per month. [1]
Key Takeaways
- 💊 Zepbound self-pay: $299–$499/month through LillyDirect, depending on dose
- 💉 Wegovy injectable self-pay: $199–$349/month through NovoCare program
- 💊 Wegovy oral pill (new in 2026): $149–$299/month, the cheapest branded GLP-1 option available
- 🏥 With insurance + savings cards: Both drugs can cost $0–$25/month
- 📋 List prices (without programs): Zepbound $1,000–$1,500/month; Wegovy $1,300–$1,800/month — almost no one pays these
- 🏛️ TrumpRx federal program: Both drugs expected at ~$350/month; Wegovy pill at ~$150/month
- 🎯 Medicare pricing (announced): ~$245/month for both, with ~$50 copay for enrollees
- ⚖️ Zepbound produces more weight loss on average (20.2% vs. 13.7%), but Wegovy has approved cardiovascular benefits
- 🔍 Vial vs. pen format matters: Zepbound vials cost significantly less than pens — worth checking before you fill a prescription
What Is the Actual Tirzepatide Price vs. Semaglutide Price in 2026?
Zepbound (tirzepatide) costs $299–$499 per month through manufacturer self-pay programs, while Wegovy (semaglutide) injectable pens cost $199–$349 per month. The new Wegovy oral pill is even cheaper at $149–$299 per month. These are the prices most uninsured patients actually pay — not the inflated list prices you might see quoted elsewhere. [1]
Here’s a clean breakdown of what each drug actually costs across different access routes:
| Access Route | Zepbound (Tirzepatide) | Wegovy Injectable | Wegovy Oral Pill |
|---|---|---|---|
| List price (no program) | $1,000–$1,500/mo | $1,300–$1,800/mo | Not yet established |
| Manufacturer self-pay | $299–$499/mo | $199–$349/mo | $149–$299/mo |
| Commercial insurance + card | $0–$25/mo | $0–$25/mo | $0–$25/mo |
| TrumpRx federal program | ~$350/mo | ~$350/mo | ~$150/mo |
| Medicare (announced) | TBD |
[1][3]
Key point: Almost nobody pays the list price. The manufacturer programs, insurance, and new federal pricing initiatives make these drugs far more accessible than headlines suggest.
“The real cost question isn’t list price vs. list price — it’s which program you qualify for and which dose you actually need.”
How Does Zepbound’s Tirzepatide Price Break Down by Dose?
Eli Lilly’s LillyDirect self-pay program prices Zepbound by dose: $299/month for 2.5 mg, $399/month for 5 mg, and $499/month for doses from 7.5 mg to 15 mg. This tiered pricing structure means your monthly cost rises as you move through the standard dosing schedule. [1]
Zepbound dosing typically starts low and increases over several months:
- 2.5 mg (starting dose): $299/month
- 5 mg (first increase): $399/month
- 7.5 mg–15 mg (maintenance range): $499/month
So if you’re budgeting for a full year of Zepbound, expect to pay around $299–$499 depending on where you land in your treatment. Most patients reach maintenance doses within 4–6 months, meaning the $499 price point applies for the majority of your treatment.
Zepbound is also available as vials, single-dose pens, and multi-dose KwikPens. The vial format is significantly cheaper than pens — sometimes saving thousands of dollars per year. For a full breakdown, see our Zepbound vial vs. pen price comparison.
Common mistake: Many patients automatically fill the pen version because it’s what gets prescribed. Always ask your provider whether the vial format is an option — the savings can be substantial.
How Does Wegovy’s Pricing Compare at Each Dose Level?
Wegovy injectable pens cost $199/month for starter doses (0.25 mg and 0.5 mg) for the first two months, then jump to $349/month for maintenance doses. The new oral Wegovy pill — launched in January 2026 after the approval in late 2025 — starts at $149/month for 1.5 mg and 4 mg doses, and $299/month for higher maintenance doses of 9 mg and 25 mg. [1]
Wegovy’s NovoCare self-pay program works like this:
- Months 1–2 (0.25 mg and 0.5 mg): $199/month
- Months 3+ (1 mg–2.4 mg maintenance): $349/month
For the oral pill:
- Starting doses (1.5 mg, 4 mg): $149/month
- Maintenance doses (9 mg, 25 mg): $299/month
The oral pill is a meaningful development. For patients who prefer not to self-inject, it’s now the cheapest branded GLP-1 option on the market. For more on semaglutide costs and savings strategies, see our guide on semaglutide without insurance costs and savings.
Choose Wegovy injectable if: You want the lowest injection cost and have cardiovascular disease (It has approved heart benefits). Choose Wegovy oral if: You prefer pills over injections and want the lowest monthly cost among branded options.
Does Insurance Cover Zepbound or Wegovy — and What Will You Actually Pay?
With commercial insurance and manufacturer savings cards, both Zepbound and Wegovy can cost as little as $0–$25 per month. Wegovy is sometimes available at $0 depending on your specific plan. However, Medicare and Medicaid generally do not cover weight loss medications, with limited exceptions. [1]
Here’s how insurance coverage typically works:
- Commercial insurance (employer-sponsored): Coverage varies widely. Many plans now include at least one GLP-1 for obesity. Using the manufacturer’s savings card alongside insurance often brings copays to $0–$25.
- Medicare: Generally does not cover weight loss drugs. An exception exists for Wegovy in patients with established cardiovascular disease, and Zepbound may be covered for certain diagnoses like sleep apnea. [1]
- Medicaid: Coverage varies by state. Most states do not cover GLP-1s for weight loss alone.
- TrumpRx federal program: The White House announced pricing of approximately $350/month for Zepbound and Wegovy, with the oral Wegovy pill at approximately $150/month. Medicare enrollees would pay approximately $245/month with copays around $50. [3]
Edge case: If you have both obesity and a qualifying condition (cardiovascular disease for Wegovy, sleep apnea for Zepbound), your insurance odds improve significantly. Always ask your doctor to document all relevant diagnoses before submitting a prior authorization.
For more on using discount programs, see our guide on GoodRx Wegovy coupons for uninsured patients.
Which Drug Gives You More Weight Loss for the Tirzepatide Price?
Zepbound produces more average weight loss than Wegovy — 20.2% vs. 13.7% of body weight — based on a head-to-head clinical trial. Both drugs are effective, but tirzepatide’s dual mechanism (GIP + GLP-1 receptor agonism) appears to drive stronger results for most patients. [1]
That said, weight loss isn’t the only metric worth comparing:
| Factor | Zepbound (Tirzepatide) | Wegovy (Semaglutide) |
|---|---|---|
| Avg. weight loss | ~20.2% of body weight | ~13.7% of body weight |
| Mechanism | GIP + GLP-1 agonist | GLP-1 agonist only |
| FDA cardiovascular approval | Not yet | ✅ Yes (SELECT trial: 20% risk reduction) |
| Formats available | Vial, pen, KwikPen | Weekly injection, daily oral pill |
| Self-pay starting cost | $299/month | $149/month (oral) / $199/month (injection) |
[1]
Wegovy’s cardiovascular advantage is real and clinically significant. The SELECT trial showed a 20% reduction in the risk of heart attack, stroke, and cardiovascular death in adults with heart disease and obesity. If you have existing heart disease, Wegovy may be the better clinical choice regardless of cost. [1]
For a deeper look at how these drugs compare for specific conditions, see our GLP-1 medications guide for weight loss and diabetes.
Are There Cheaper Alternatives to Both Drugs?
Yes — compounded tirzepatide and semaglutide have been available at lower prices, though their legal and safety status is evolving in 2026. Telehealth platforms have offered compounded versions for $149–$300/month, but oversight of compounded GLP-1s has tightened significantly. [4]
Other cost-reduction strategies worth knowing:
- Use the manufacturer’s self-pay program first — LillyDirect and NovoCare are the most reliable starting points.
- Ask about vials instead of pens — Zepbound vials cost substantially less. See our full tirzepatide cost breakdown for specifics.
- Check GoodRx and other discount platforms — prices vary by pharmacy and location.
- Apply for patient assistance programs — both Eli Lilly and Novo Nordisk offer assistance for qualifying low-income patients.
- Explore the TrumpRx program — if eligible, this federal initiative may offer the lowest available pricing for Zepbound and Wegovy. See our TrumpRx weight loss prices guide for details.
- Consider the oral Wegovy pill — at $149/month for starting doses, it’s currently the cheapest branded GLP-1 option available.
For a broader comparison of low-cost GLP-1 options, see our guide to cheap weight loss injections in 2026.
FAQ: Zepbound vs. Wegovy Cost Questions Answered
Q: Is Zepbound cheaper than Wegovy? A: For injectable self-pay programs, Wegovy is slightly cheaper ($199–$349/month vs. $299–$499/month for Zepbound). The new oral Wegovy pill at $149/month is the cheapest branded option overall. [1]
Q: What is the tirzepatide price without insurance? A: Through Eli Lilly’s LillyDirect program, Zepbound costs $299/month (2.5 mg), $399/month (5 mg), or $499/month (7.5 mg–15 mg). Without any program, list prices run $1,000–$1,500/month. [1]
Q: Does Medicare cover Zepbound or Wegovy? A: Generally no, not for weight loss alone. Exceptions may apply for Wegovy if you have cardiovascular disease, or Zepbound if you have sleep apnea. The announced federal pricing program would set Medicare costs at approximately $245/month with ~$50 copays. [1][3]
Q: Can I get Zepbound or Wegovy for $25 or less per month? A: Yes, if you have commercial insurance that covers GLP-1s and use the manufacturer’s savings card. Both drugs can reach $0–$25/month through this combination. [1]
Q: Which drug works better for weight loss? A: Zepbound produced 20.2% average body weight loss vs. 13.7% for Wegovy in a head-to-head trial. However, Wegovy has approved cardiovascular benefits that Zepbound does not yet have. [1]
Q: What is the Wegovy oral pill, and how much does it cost? A: Novo Nordisk launched an oral semaglutide pill (Wegovy) in January 2026 after approval in late 2025. It costs $149/month for starting doses and $299/month for maintenance doses — the cheapest branded GLP-1 currently available. [1]
Q: Is the TrumpRx program available now for Zepbound and Wegovy? A: The White House announced pricing of approximately $350/month for injectable versions and $150/month for the Wegovy pill through this program. Availability and enrollment details are still rolling out as of March 2026. [3]
Q: Are Zepbound vials cheaper than pens? A: Yes, significantly. Zepbound vials cost much less than single-dose pens for the same dose. This is one of the most overlooked cost-saving strategies for tirzepatide users.
Q: What’s the list price of Zepbound vs. Wegovy? A: Zepbound’s retail list price is approximately $1,000–$1,500/month. Wegovy’s is approximately $1,300–$1,800/month. Most patients do not pay these prices due to savings programs. [1][2]
Q: Should I choose Zepbound or Wegovy if I have heart disease? A: Wegovy is the stronger clinical choice for patients with established cardiovascular disease. The SELECT trial showed a 20% reduction in heart attack, stroke, and cardiovascular death risk — a benefit Zepbound does not yet have approval for. [1]
Conclusion: Which Drug Is Actually Worth the Cost?
Wegovy is cheaper for most self-pay patients in 2026, especially with the new oral pill at $149/month. Zepbound costs more out of pocket ($299–$499/month), but produces meaningfully greater weight loss on average (20.2% vs. 13.7%). With insurance, the cost difference largely disappears — both can reach $0–$25/month.
Here’s how to decide:
- Choose Wegovy if you have cardiovascular disease, prefer the oral pill format, or are uninsured and want the lowest monthly cost.
- Choose Zepbound if maximizing weight loss is your primary goal and you’re comfortable with the higher self-pay cost — or if your insurance covers it.
- Check the vial option for Zepbound before filling any prescription. The savings can be significant.
- Apply to manufacturer programs first — LillyDirect and NovoCare are your best starting points before exploring third-party discount platforms.
- Watch the TrumpRx and federal pricing programs — if the announced $150–$350/month pricing rolls out fully, it will change the calculus for many patients.
The tirzepatide price vs. semaglutide price debate ultimately comes down to your health profile, insurance situation, and weight loss goals. Talk to your doctor about which drug fits your specific needs — and then work the savings programs hard to bring the cost down as far as possible.
References
[1] Zepbound Vs Wegovy Cost – https://www.meetaugust.ai/en/library/blog/view/zepbound-vs-wegovy-cost
[2] Blog – https://www.doctorlarocca.com/blog/6
[3] Weight Loss Drugs Price Drop – https://www.aarp.org/health/drugs-supplements/weight-loss-drugs-price-drop/
[4] Zepbound Vs Wegovy – https://www.goodrx.com/compare/zepbound-vs-wegovy
With over 13 years of experience in holistic health blogging, I aim to help you navigate your wellness journey with honest insights, expert-backed advice, and a sprinkle of real-world practicality.
Certified Wellness Writer | Herbal Nutrition Advocate | Wellness Research Enthusiast
